Author: claimsbot

1. An ammonia compound concentration measuring device which measures an ammonia compound concentration of a measurement subject contained in a circulating gas, the ammonia compound concentration measuring device comprising:
a pipe unit through which the circulating gas flows;
a converter which is disposed in the pipe unit and converts an ammonia compound contained in the circulating gas passing through the converter into ammonia;
a measurement device which measures a first measurement value as a concentration of ammonia contained in a first circulating gas flowing inside a pipe line with the converter out of the circulating gas flowing inside the pipe unit, and measures a second measurement value as a concentration of ammonia contained in a second circulating gas flowing inside a pipe line without the converter out of the circulating gas flowing inside the pipe unit; and
a controller which controls operations of the pipe unit and the measurement device, and calculates the concentration of the ammonia compound contained in the circulating gas from a difference between the first measurement value and the second measurement value,
wherein the measurement device includes
a light emitting portion which outputs a laser beam having a wavelength absorbed by the ammonia and being in a near-infrared wavelength band,
at least one measurement unit which includes a gas measurement cell causing the circulating gas to flow therethrough, an optical system causing a laser beam to be incident to the gas measurement cell, and a light receiving portion receiving the laser beam incident from the light emitting portion and passing through the gas measurement cell, and
a calculation portion which calculates the measurement value of the ammonia of the circulating gas flowing through the gas measurement cell based on the intensity of the laser beam output from the light emitting portion and the intensity of the laser beam received by the light receiving portion.
2. The ammonia compound concentration measuring device according to claim 1, further comprising:
a first flowmeter which is disposed at the upstream side in relation to the converter and measures a flow rate of the circulating gas flowing into the converter; and
a second flowmeter which is disposed at the downstream side in relation to the converter and measures a flow rate of the circulating gas discharged from the converter,
wherein the controller corrects and calculates a measurement value of the ammonia of the circulating gas based on a measurement result of the first flowmeter and a measurement result of the second flowmeter.
3. The ammonia compound concentration measuring device according to claim 1,
wherein the pipe unit includes
an inflow pipe into which the circulating gas flows,
a first pipe which is connected to the downstream side end portion of the inflow pipe in the circulating gas flow direction and is provided with the converter,
a second pipe which is connected to the downstream side end portion of the inflow pipe in the circulating gas flow direction together with the first pipe and is not provided with the converter, and
a three-way valve which is connected to the downstream side end portion of the first pipe, the downstream side end portion of the second pipe, and the upstream side end portion of the gas measurement cell in the circulating gas flow direction,

wherein the controller connects the downstream side end portion of the first pipe to the upstream side end portion of the gas measurement cell in the circulating gas flow direction by the three-way valve so as to cause the first circulating gas to flow into the measurement device and measures the first measurement value, and
wherein the controller connects the downstream side end portion of the second pipe to the upstream side end portion of the gas measurement cell in the circulating gas flow direction by the three-way valve so as to cause the second circulating gas to flow into the measurement device, and measures the second measurement value.
4. The ammonia compound concentration measuring device according to claim 1,
wherein the pipe unit includes
an inflow pipe into which the circulating gas flows,
a first pipe which is connected to the downstream side end portion of the inflow pipe in the circulating gas flow direction and is provided with the converter, and
a second pipe which is connected to the downstream side end portion of the inflow pipe in the circulating gas flow direction together with the first pipe and is not provided with the converter,

wherein the measurement device includes two measurement units, one measurement unit is disposed at the downstream side in relation to the converter in the circulating gas flow direction of the first pipe, and the other measurement unit is disposed in the first pipe.
5. The ammonia compound concentration measuring device according to claim 1,
wherein the pipe unit includes
an inflow pipe into which the circulating gas flows, and
a retention pipe which is connected to the downstream side end portion of the inflow pipe in the circulating gas flow direction and is provided with the converter,

wherein the measurement device includes two measurement units, one measurement unit is disposed at the downstream side in relation to the converter in the circulating gas flow direction of the retention pipe, and the other measurement unit is disposed at the upstream side in relation to the converter in the circulating gas flow direction of the retention pipe.
6. The ammonia compound concentration measuring device according to claim 1,
wherein the converter is a thermal decomposition layer which thermally decomposes an ammonia compound into ammonia.
7. The ammonia compound concentration measuring device according to claim 6,
wherein the converter includes a temperature adjusting portion which adjusts a temperature of the thermal decomposition layer.
8. The ammonia compound concentration measuring device according to claim 1, further comprising:
a switching unit which selects an execution or a stop of the conversion operation of the converter,
wherein the pipe unit includes
an inflow pipe into which the circulating gas flows, and
a retention pipe which is connected to the downstream side end portion of the inflow pipe in the circulating gas flow direction and is provided with the converter,

wherein in the measurement device, the measurement unit is disposed at the downstream side in relation to the converter in the circulating gas flow direction of the retention pipe,
wherein the converter is a thermal decomposition layer which thermally decomposes an ammonia compound into ammonia,
wherein the switching unit is a temperature adjusting portion which adjusts a temperature of the thermal decomposition layer, and
wherein the controller selects a state where the conversion operation of the converter is executed or a state where the conversion operation of the converter is stopped so as to select a state where the first circulating gas flows into the measurement unit or a state where the second circulating gas flows thereinto.
9. The ammonia compound concentration measuring device according to claim 8,
wherein the switching unit causes the temperature adjusting portion to heat the circulating gas up to a temperature at which the ammonia compound is decomposed so that the conversion operation of the converter is executed and to stop the heating of the circulating gas so that the conversion operation of the converter is stopped.
10. The ammonia compound concentration measuring device according to claim 1,
wherein the converter further includes a collection layer which collects the ammonia compound.
11. The ammonia compound concentration measuring device according to claim 1,
wherein in the measurement unit, a laser beam passes inside a pipe which retains the converter.
12. The ammonia compound concentration measuring device according to claim 1,
wherein an entire amount of the circulating gas discharged from a device of the measurement subject flows inside the pipe unit.
13. The ammonia compound concentration measuring device according to claim 1,
wherein the pipe unit collects a part of the circulating gas from a measurement subject pipe through which an entire amount of the circulating gas discharged from the device of the measurement subject flows.
14. An ammonia compound concentration measuring method which measures an ammonia compound concentration of a circulating gas flowing inside a pipe, the ammonia compound concentration measuring method comprising:
a first measurement step of outputting a laser beam having a wavelength absorbed by ammonia and being in a near-infrared wavelength band to a first circulating gas passing through a region provided with a converter for converting an ammonia compound into ammonia in the circulating gas flowing inside the pipe, receiving the laser beam passing through a pipe line through which the first circulating gas flows, and measuring a concentration of the ammonia contained in the first circulating gas as a first measurement value based on the intensity of the output laser beam and the intensity of the laser beam received by a light receiving portion;
a second measurement step of outputting a laser beam having a wavelength absorbed by ammonia and being in a near-infrared wavelength band to a second circulating gas not passing through a region provided with a converter for converting an ammonia compound into ammonia in the circulating gas flowing inside the pipe, receiving the laser beam passing through a pipe line through which the second circulating gas flows, and measuring a concentration of the ammonia contained in the circulating gas as a second measurement value based on the intensity of the output laser beam and the intensity of the laser beam received by the light receiving portion; and
a calculation step of calculating a measurement value of the concentration of the ammonia compound contained in the circulating gas from a difference between the first measurement value and the second measurement value.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A complex data processing device that processes embroidery data representing an embroidery pattern to be formed on fabric by a sewing machine capable of embroidering and print data representing print pattern to be printed on the fabric by a printer, the complex data processing device comprising:
a data acquiring unit that acquires the embroidery data and the print data;
an overlapped region detecting unit that detects an overlapped region at which an embroidery region represented by the embroidery data and a printing region represented by the print data overlap based on the embroidery data and the print data acquired by the data acquiring unit; and
a data modifying unit that deletes data corresponding to the overlapped region detected by the overlapped region detecting unit from at least one of the embroidery data and the print data.
2. The complex data processing device according to claim 1, wherein;
the data modifying unit modifies the print data such that overlapped region print data corresponding to the overlapped region is deleted from the print data.
3. The complex data processing device according to claim 2, wherein:
the data modifying unit includes a first overlapped region setting unit; and
when the overlapped region detecting unit detects multiple overlapped regions, the first overlapped region setting unit sets whether overlapped region print data corresponding to each of multiple overlapped regions is to be deleted from the print data.
4. The complex data processing device according to claim 2, wherein:
the data modifying unit deletes the overlapped region print data from the print data so that a width of the overlapped region is modified by a predetermined amount in one of a direction where the overlapped region is reduced and a direction where the overlapped region is expanded.
5. The complex data processing device according to claim 1, wherein:
the data modifying unit modifies the embroidery data such that overlapped region embroidery data is deleted from the embroidery data.
6. The complex data processing device according to claim 5, wherein:
the data modifying unit includes a second overlapped region setting unit; and
when the overlapped region detecting unit detects multiple overlapped regions, the second overlapped region setting unit sets whether overlapped region embroidery data corresponding to each of multiple overlapped regions is to be deleted from the embroidery data.
7. The complex data processing device according to claim 5, wherein:
the data modifying unit deletes the overlapped region embroidery data from the embroidery data so that a width of the overlapped region is modified by a predetermined amount in one of a direction where the overlapped region is reduced and a direction where the overlapped region is expanded.
8. A complex data processing device that processes embroidery data representing an embroidery pattern to be formed on fabric by a sewing machine capable of embroidering and print data representing print pattern to be printed on the fabric by a printer, the complex data processing device comprising:
a data acquiring unit that acquires the embroidery data and the print data;
an overlapped region detecting unit that detects an overlapped region at which an embroidery region represented by the embroidery data and a printing region represented by the print data overlap based on the embroidery data and the print data acquired by the data acquiring unit; and
a process order setting unit allowing a user to set the order of embroidering based on the embroidery data and printing based on the print data when the overlapped region detecting unit detects the overlapped region, the processing order setting unit storing the order set by the user.
9. The complex data processing device according to claim 8, further comprising:
a data modifying unit configured to delete overlapped region print data corresponding to the overlapped region from the print data if it is set through the process order setting unit that the printing is performed prior to the embroidering.
10. The complex data processing device according to claim 8, further comprising:
a thread density compensating unit configured to modify the embroidery data to change a thread density at the overlapped region, the thread density compensating unit modifying the embroidery data to increase the thread density of the embroidery at the overlapped region if it is set through the process order setting unit that the printing is performed prior to the embroidering.
11. A computer-readable storage medium storing a computer-executable program, the program usable to cause a computer to serve as a complex data processing device that processes embroidery data representing an embroidery pattern to be formed on fabric by a sewing machine capable of embroidering and print data representing print pattern to be printed on the fabric by a printer,
the program comprising:
instructions for causing a data acquiring unit to acquire the embroidery data and the print data;
instructions for causing an overlapped region detecting unit to detect an overlapped region at which an embroidery region represented by the embroidery data and a printing region represented by the print data overlap based on the embroidery data and the print data acquired by the data acquiring unit; and
instructions for causing a data modifying unit to delete data corresponding to the overlapped region detected by the overlapped region detecting unit from at least one of the embroidery data and the print data.
12. The computer-readable storage medium according to claim 11, wherein the program further comprises:
instructions for causing the data modifying unit to modify the print data such that overlapped region print data corresponding to the overlapped region is deleted from the print data.
13. The computer-readable storage medium according to claim 12, wherein:
the data modifying unit includes a first overlapped region setting unit; and
the program further comprises instructions for causing the first overlapped region setting unit to set whether overlapped region print data corresponding to each of multiple overlapped regions is to be deleted from the print data when the overlapped region detecting unit detects multiple overlapped regions.
14. The computer-readable storage medium according to claim 12, wherein the program further comprises:
instructions for causing the data modifying unit to delete the overlapped region print data from the print data so that a width of the overlapped region is modified by a predetermined amount in one of a direction where the overlapped region is reduced and a direction where the overlapped region is expanded.
15. The computer-readable storage medium according to claim 11, wherein the program further comprises:
instructions for causing the data modifying unit to modify the embroidery data such that overlapped region embroidery data is deleted from the embroidery data.
16. The computer-readable storage medium according to claim 15, wherein:
the data modifying unit includes a second overlapped region setting unit; and
the program further comprises instructions for causing the second overlapped region setting unit to set whether overlapped region embroidery data corresponding to each of multiple overlapped regions is to be deleted from the embroidery data when the overlapped region detecting unit detects multiple overlapped regions.
17. The computer-readable storage medium according to claim 15, wherein the program further comprises:
instructions for causing the data modifying unit to delete the overlapped region embroidery data from the embroidery data so that a width of the overlapped region is modified by a predetermined amount in one of a direction where the overlapped region is reduced and a direction where the overlapped region is expanded.
18. A computer-readable storage medium storing a computer-executable usable to cause a computer to serve as complex data processing device that processes embroidery data representing an embroidery pattern to be formed on fabric by a sewing machine capable of embroidering and print data representing print pattern to be printed on the fabric by a printer,
the program comprising:
instructions for causing a data acquiring unit to acquire the embroidery data and the print data;
instructions for causing an overlapped region detecting unit to detect an overlapped region at which an embroidery region represented by the embroidery data and a printing region represented by the print data overlap based on the embroidery data and the print data acquired by the data acquiring unit;
instructions for causing a process order setting unit to allow a user to set the order of embroidering based on the embroidery data and printing based on the print data when the overlapped region detecting unit detects the overlapped region; and
instructions for causing the processing order setting unit to store the order set by the user.
19. The computer-readable storage medium
according to claim 18, wherein the program further comprises:
instructions for causing a data modifying unit to delete overlapped region print data corresponding to the overlapped region from the print data if it is set through the process order setting unit that the printing is performed prior to the embroidering.
20. The computer-readable storage medium according to claim 18, wherein the program further comprises:
instructions for causing a thread density compensating unit to modify the embroidery data to change a thread density at the overlapped region; and
instructions for causing the thread density compensating unit to modify the embroidery data to increase the thread density of the embroidery at the overlapped region if it is set through the process order setting unit that the printing is performed prior to the embroidering.

1. A liquid crystal display device comprising:
a first substrate comprising:
a plurality of data electrodes;
a plurality of gate electrodes arranged to intersect the data electrodes; and
a plurality of pixels, each of the pixels including a thin film transistor and a pixel electrode, each of the pixels coupled to one of the data lines and one of the gate lines;
a second substrate facing the first substrate, the second substrate comprising:
a plurality of color filters, each of the color filters facing one of the pixel electrodes; and
a black matrix formed on a region in which the color filters are not formed, the black matrix having openings that expose the gate electrodes; and
a liquid crystal layer disposed between the first substrate and the second substrate,
wherein the openings alternate on opposite sides of the color filters with no openings adjacent to each other.
2. The liquid crystal display device as claimed in claim 1, wherein one of the pixels disposed by one side of a first one of the data electrodes is coupled to a first one of the gate electrodes, and another of the pixels disposed by an opposite side of the first one of the data electrodes is coupled to a second one of the gate electrodes.
3. The liquid crystal display device as claimed in claim 2, wherein both of the one of the pixels and the another of the pixels are coupled to the first one of the data electrodes.
4. The liquid crystal display device as claimed in claim 2, wherein both of the one of the pixels and the another of the pixels are disposed between the first one of the gate electrodes and the second one of the gate electrodes.
5. The liquid crystal display device as claimed in claim 4, wherein:
one of the openings is formed on the second one of the gate electrodes, the one of the openings being formed between the first one of the data electrodes and a second one of the data electrodes located by the one side of the first one of the data electrodes; and
another of the openings is formed on the first one of the gate electrodes, the another of the openings being formed between the first one of the data electrodes and a third one of the data electrodes located by the opposite side of the first one of the data electrodes.
6. The liquid crystal display device as claimed in claim 5, wherein:
no opening is formed on a portion of the first one of the gate electrodes located between the first one of the data electrodes and the second one of the data electrodes; and
no opening is formed on a portion of the second one of the gate electrodes located between the first one of the data electrodes and the third one of the data electrodes.
7. The liquid crystal display device as claimed in claim 1, wherein one of the pixels disposed by one side of one of the data electrodes and another of the pixels disposed by an opposite side of the one of the data electrodes are both coupled to the one of the data electrodes.
8. The liquid crystal display device as claimed in claim 7, wherein the one of the pixels and the another of the pixels are coupled to different ones of the gate electrodes.
9. The liquid crystal display device as claimed in claim 8, wherein the one of the pixels and the another of the pixels are both disposed between the different ones of the gate electrodes.
10. The liquid crystal display device as claimed in claim 1, wherein each of the openings exposes a portion of one of the gate electrodes located between two of the data electrodes.
11. The liquid crystal display device as claimed in claim 1, wherein each of the color filters is arranged between two of the openings.
12. The liquid crystal display device as claimed in claim 11, wherein the two of the openings are aligned in a direction substantially parallel to one of the data electrodes.
13. The liquid crystal display device as claimed in claim 1, wherein at least two of the color filters are arranged between nearest two of the openings.
14. The liquid crystal display device as claimed in claim 13, wherein the nearest two of the openings are aligned in a direction substantially parallel to one of the data electrodes.
15. The liquid crystal display device as claimed in claim 1, wherein at least two of the pixels are disposed between two of the data electrodes.
16. The liquid crystal display device as claimed in claim 15, wherein one of the at least two of the pixels is coupled to a first one of the gate electrodes, and another of the at least two of the pixels is coupled to a second one of the gate electrodes.
17. The liquid crystal display device as claimed in claim 15, wherein the one of the at least two of the pixels and the another of the at least two of the pixels are both formed between the first one of the gate electrodes and the second one of the gate electrodes.
18. The liquid crystal display device as claimed in claim 15, wherein:
one of the openings is formed on the second one of the gate electrodes at a location closer to the one of the at least two of the pixels than the another of the at least two of the pixels; and
another of the openings is formed on the first one of the gate electrodes at a location closer to the another of the at least two of the pixels than the one of the at least two of the pixels.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A conjugated compound comprising:
a) a ST receptor binding moiety; and
b) an active moiety;
wherein said active moiety is a radiostable active agent.
2. The compound of claim 1 wherein said ST receptor binding moiety is a peptide.
3. The compound of claim 1 wherein said ST receptor binding moiety is selected from the group consisting of: SEQ ID NO:2, SEQ ID NO:3, SEQ ID NOS:5-54 and fragments and derivatives thereof.
4. The compound of claim 1 wherein said ST receptor binding moiety is selected from the group consisting of SEQ ID:2, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:6 and SEQ ID NO:54.
5. The compound of claim 1 wherein said active moiety is a therapeutic agent.
6. The compound of claim 1 wherein said active moiety is selected from the group consisting of: methotrexate, doxorubicin, daunorubicin, cytosinarabinoside, etoposide, 5-4 fluorouracil, melphalan, chlorambucil, cis-platin, vindesine, mitomycin, bleomycin, purothionin, macromomycin, 1,4-benzoquinone derivatives, trenimon, ricin, ricin A chain, Pseudomonas exotoxin, diphtheria toxin, Clostridium perfringens phospholipases C, bovine pancreatic ribonuclease, pokeweek antiviral protein, abrin, abrin A chain, cobra venom factor, gelonin, saporin, modeccin, viscumin, volkensin, alkaline phosphatase, nitroimidazole, metronidazole and misonidazole.
7. The compound of claim 1 wherein:
a) said ST receptor binding moiety is selected from the group consisting of: SEQ ID NO:2, SEQ ID NO:3, SEQ ID NOS:5-54 and fragments and derivatives thereof;
b) said an active moiety is selected from the group consisting of: methotrexate, doxorubicin, daunorubicin, cytosinarabinoside, etoposide, 5-4 fluorouracil, melphalan, chlorambucil, cis-platin, vindesine, mitomycin, bleomycin, purothionin, macromomycin, 1,4-benzoquinone derivatives, trenimon, ricin, ricin A chain, Pseudomonas exotoxin, diphtheria toxin, Clostridium perfringens phospholipases C, bovine pancreatic ribonuclease, pokeweed antiviral protein, abrin, abrin A chain, cobra venom factor, gelonin, saporin, modeccin, viscumin, volkensin, alkaline phosphatase, nitroimidazole, metronidazole and misonidazole.
8. The compound of claim 1 wherein said an active moiety is selected from the group consisting of: methotrexate, doxorubicin, daunorubicin, cytosinarabinoside, cis-platin, vindesine, mitomycin and bleomycin, alkaline phosphatase, ricin A chain, Pseudomonas exotoxin and diphtheria toxin.
9. The compound of claim 1 wherein:
a) said ST receptor binding moiety is selected from the group consisting of: SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:6 and SEQ ID NO:54; and
b) said an active moiety is selected from the group consisting of: methotrexate, doxorubicin, daunorubicin, cytosinarabinoside, cis-platin, vindesine, mitomycin and bleomycin, alkaline phosphatase, ricin A chain, Pseudomonas exotoxin and diphtheria toxin.
10. A pharmaceutical composition comprising:
a) a pharmaceutically acceptable carrier or diluent, and
b) a conjugate compound according to claim 1.
11. A method of treating an individual suspected of suffering from metastasized colorectal cancer comprising the steps of administering to said individual a pharmaceutical composition according to claim 10.
12. A pharmaceutical composition comprising:
a) a pharmaceutically acceptable carrier or diluent, and,
b) conjugated compound comprising:
i) a ST receptor binding moiety; and
ii) an active moiety wherein said active moiety is a radioactive agent and said conjugated compound is present in an amount effective for therapeutic or diagnostic use in humans suffering from colorectal cancer.
13. The pharmaceutical composition of claim 12 wherein said active moiety is selected from the group consisting of: 47Sc, 67Cu, 90Y, 109Pd, 123I, 125I, 131I, 186Re, 199Au, 211At, 212Pb, 212B, 32P, 33P, 77Ge, 77As, 103Pb, 105Rh, 111Ag, 119Sb, 121Sn, 131Cs, 143Pr, 161Tb, 177Lu, 191Os, 193MPt and 197Hg.
14. The pharmaceutical composition of claim 12 wherein said active moiety is selected from the group consisting of: 43K, 52Fe, 57Co, 67Cu, 67Ga, 68Ga, 77Br, 81Rb81MKr, 87MSr, 99MTc, 111In, 113In, 123I, 125I, 127Cs, 129Cs, 131I, 132I, 197Hg, 203Pb and 206Bi.
15. The pharmaceutical composition of claim 12 wherein said ST receptor binding moiety is a peptide.
16. The pharmaceutical composition of claim 12 wherein said ST receptor binding moiety is selected from the group consisting of: SEQ ID NO:2, SEQ ID NO:3, SEQ ID NOS:5-54 and fragments and derivatives thereof.
17. The pharmaceutical composition of claim 12 wherein said ST receptor binding moiety is selected from the group consisting of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:6 and SEQ ID NO:54.
18. The pharmaceutical composition of claim 12 wherein said ST receptor binding moiety is selected from the group consisting of: SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:6 and SEQ ID NO:54, and said active moiety is selected from the group consisting of: 47Sc, 67Cu, 90Y, 109Pd, 123I, 125I, 131I, 186Re, 188Re, 199Au, 211At, 212Pb, 212B, 32P and 33P, 71Ge, 77As, 103Pb, 105Rh, 111Ag, 119Sb, 121Sn, 131Cs, 143Pr, 161Tb, 177Lu, 191Os, 193MPt and 197Hg.
19. The pharmaceutical composition of claim 12 wherein said ST receptor binding moiety is selected from the group consisting of: SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO.5, SEQ ID NO:6 and SEQ ID NO:54, and said active moiety is selected from the group consisting of 43K, 53Fe, 57Co, 67Cu, 67Ga, 68Ga, 77Br, 81Rb81MKr, 87MSr, 99MTc, 111In, 123I, 125I, 127Cs, 129Cs, 131I, 132I, 197Hg, 203Pb and 206Bi.
20. A method of radioimaging metastasized colorectal cancer cells comprising the steps of administering to an individual a pharmaceutical composition comprising:
a) a pharmaceutically acceptable carrier or diluent, and
b) conjugated compound comprising:
i) a ST receptor binding moiety; and
ii) an active moiety;
wherein said active moiety is a radioactive agent and said conjugated compound is present in an amount effective for diagnostic use in humans suffering from colorectal cancer.
21. A method of treating an individual suspected of suffering from metastasized colorectal cancer comprising the steps of administering to said individual a pharmaceutical composition comprising:
a) a pharmaceutically acceptable carrier or diluent, and,
b) conjugated compound comprising:
i) a ST receptor binding moiety; and
ii) an active moiety;
wherein said active moiety is a radiostable agent or radioactive agent and said conjugated compound is present in an amount effective for therapeutic or diagnostic use in humans suffering from colorectal cancer.
22. A method of delivery of a nucleic acid molecule to intestinal tract cells of an individual comprising the steps of administering to said individual a pharmaceutical composition comprising:
a) a pharmaceutically acceptable carrier or diluent, and,
b) a composition comprising:
i) a ST receptor ligand; and
ii) a nucleic acid molecule.
23. A method of treating an individual suspected of suffering from metastasized colorectal cancer comprising the steps of administering to said individual:
a) a conjugated compound comprising an ST receptor binding moiety and an enzyme; and
b) a prodrug which when processed by the enzyme is converted to a drug.
24. The method of claims 23 wherein:
a) a conjugated compound comprises an ST receptor binding moiety and alkaline phosphatase; and
b) the prodrug is etoposidephosphate.
25. The compound of claim 1 wherein said active moiety is an enzyme.
26. The compound of claim 25 wherein said active moiety is alkaline phosphatase.